Trending

China

Nine for 2019: Opportunities for pharma

Nine for 2019: Opportunities for pharma

In the last Nine for 2019 article, we reflected on the major challenges that are shaping the pharmaceutical

X

Nine for 2019: Opportunities for pharma

https://pharmaphorum.com/views-and-analysis/nine-for-2019-opportunities-for-pharma/

China in the fast lane

China in the fast lane

Brett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest

X

China in the fast lane

https://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/research-partnership-pharma-market-access-china/

Pfizer strikes deal with Chinese online pharmacy Jianke

Pfizer strikes deal with Chinese online pharmacy Jianke

Pfizer is set to implement a new retail, hospital services and internet healthcare strategy in China as part

X

Pfizer strikes deal with Chinese online pharmacy Jianke

https://pharmaphorum.com/news/pfizer-chinese-online-pharmacy-jianke/

Roche’s Alecensa fast-tracked in China

Roche’s Alecensa fast-tracked in China

China’s national regulator has granted a rapid approval for Roche’s lung cancer treatment Alecensa just months after European

X

Roche’s Alecensa fast-tracked in China

https://pharmaphorum.com/news/roches-alecensa-fast-tracked-china/

Chinese pharma contaminated with scandals

Chinese pharma contaminated with scandals

Another batch of vaccines have been found “substandard”, just days after the second-largest pharmaceutical company in China admitted

X

Chinese pharma contaminated with scandals

https://pharmaphorum.com/news/chinese-pharma-contaminated-scandals/

China strives to lower cost of cancer drugs as disease rates soar

China strives to lower cost of cancer drugs as disease rates soar

China is pushing domestic and overseas markets to lower the cost of cancer drugs to make them more

X

China strives to lower cost of cancer drugs as disease rates soar

https://pharmaphorum.com/news/china-cancer-drug-pricing/

Biotech eyes Chinese opportunities and seek local partners

Biotech eyes Chinese opportunities and seek local partners

Biotech companies see China as one of the biggest healthcare opportunities, but would need partnerships before approaching the

X

Biotech eyes Chinese opportunities and seek local partners

https://pharmaphorum.com/news/biotech-china-partnerships/

Trump’s trade war with China could drive up US pharma costs

Trump’s trade war with China could drive up US pharma costs

New tariffs on goods coming from China could hit the US pharmaceutical industry, according to a new analysis

X

Trump’s trade war with China could drive up US pharma costs

https://pharmaphorum.com/news/trumps-trade-war-with-china-could-drive-up-us-pharma-costs/

Local partnerships key to pharma’s success in China

Local partnerships key to pharma’s success in China

China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.

X

Local partnerships key to pharma’s success in China

https://pharmaphorum.com/views-and-analysis/local-partnerships-key-pharmas-success-china/

1 2

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com